My Blue Dots – Page 8

Zoning out could be beneficial—and may actually help us learn faster

MyBlueDots1 week ago01 mins

Aimlessly wandering around a city or exploring the new mall may seem unproductive, but new research from HHMI’s Janelia Research Campus suggests it could play an important role in how our brains learn.

Heart valve for young children shines in early-stage preclinical testing

MyBlueDots1 week ago01 mins

Researchers at the University of California, Irvine have successfully performed preclinical laboratory testing of a replacement heart valve intended for toddlers and young children with congenital cardiac defects, a key step toward obtaining approval for human use. The results of their study were published recently in the Journal of the American Heart Association.

Macrophages elicit separate pathways for inflammation and lysosomal function in diseases due to toxic particle exposure

MyBlueDots1 week ago01 mins

Human exposure to toxic particles drives various diseases. Examples include gout, an acute arthritis driven by monosodium urate crystals, or MSUc; CPPD disease, another inflammatory joint disease driven by calcium pyrophosphate dihydrate crystals, or CPPDc; and the lung disease silicosis, driven by inhaled silica-derived nanoparticles.

Weekly semaglutide improves blood sugar and weight in adults with type 1 diabetes, clinical trial finds

MyBlueDots1 week ago01 mins

A new clinical trial found that taking a popular diabetes and weight-loss drug once weekly significantly improves blood sugar and leads to substantial weight loss in adults with type 1 diabetes who use automated insulin delivery systems.

AI chatbot safeguards fail to prevent spread of health disinformation, study reveals

MyBlueDots1 week ago01 mins

A study assessed the effectiveness of safeguards in foundational large language models (LLMs) to protect against malicious instruction that could turn them into tools for spreading disinformation, or the deliberate creation and dissemination of false information with the intent to harm.

FDA approves Monjuvi for relapsed, refractory follicular lymphoma

MyBlueDots1 week ago01 mins

The U.S. Food and Drug Administration has approved Monjuvi (tafasitamab-cxix) for the treatment of adult patients with relapsed or refractory follicular lymphoma.

Dual-targeting radiopharmaceutical therapy safe and effective across multiple cancers

MyBlueDots1 week ago01 mins

A new cancer treatment that delivers radiation directly to tumors by targeting two key markers simultaneously has been shown to be safe and effective in human trials. Acting like a “smart missile,” the dual-targeting radiopharmaceutical is designed to attach to two vulnerable sites on cancer cells, enabling more precise and potent therapy. Early results show that nearly 90% of patients experienced either tumor shrinkage or disease stabilization. These findings were presented at the Society of Nuclear Medicine and Molecular Imaging 2025 Annual Meeting.

New PET tracer delivers high-quality images of brain inflammation activity

MyBlueDots1 week ago01 mins

A newly developed PET radiotracer has shown the ability to produce high-quality images of real-time brain inflammation, according to research presented at the Society of Nuclear Medicine and Molecular Imaging 2025 Annual Meeting and published as a supplement in the Journal of Nuclear Medicine.

PET imaging links brain inflammation to speech disorder and Parkinson-like syndrome

MyBlueDots1 week ago01 mins

A novel PET imaging approach has revealed distinct patterns of brain inflammation in patients with progressive apraxia of speech (PAOS), a rare neurodegenerative disorder that affects speech planning. These findings provide new insight into how neuroinflammation and tau pathology may drive disease progression in PAOS, opening potential avenues for earlier diagnosis and targeted treatments.

Hydrops MRI accurately differentiates Meniere disease and vestibular migraine

MyBlueDots1 week ago01 mins

The combination of cochlear endolymphatic hydrops (CEH) and vestibular endolymphatic hydrops (VEH) on magnetic resonance imaging (MRI) accurately diagnoses Meniere disease (MD) and vestibular migraine (VM), according to a study published online May 13 in Frontiers in Neurology.

Useful _Links

Gene signature of hepatic ferroptosis reveals its pathogenic features

An AI-based classification system for facial pigmented lesions

Engineers create first immunocompetent leukemia device for CAR T immunotherapy screening

Improvements to patient recovery strategies lower long-term opioid usage after colorectal surgery

Proteins important in brain communication have different roles than previously thought

Hidden bias may leave women and older adults underdiagnosed for HIV in Spain

Zoning out could be beneficial—and may actually help us learn faster

Heart valve for young children shines in early-stage preclinical testing

Macrophages elicit separate pathways for inflammation and lysosomal function in diseases due to toxic particle exposure

Weekly semaglutide improves blood sugar and weight in adults with type 1 diabetes, clinical trial finds

AI chatbot safeguards fail to prevent spread of health disinformation, study reveals

FDA approves Monjuvi for relapsed, refractory follicular lymphoma

Dual-targeting radiopharmaceutical therapy safe and effective across multiple cancers

New PET tracer delivers high-quality images of brain inflammation activity

PET imaging links brain inflammation to speech disorder and Parkinson-like syndrome

Hydrops MRI accurately differentiates Meniere disease and vestibular migraine

World News

Useful Links

Health

Business

Entertainment

About Us